美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Opthea Limited

0.4400

+0.0000

成交量：- -

成交額：- -

市值：5.42億

市盈率：-1.67

高：0.4400

開：0.4400

低：0.4400

收：0.4400

資料載入中...

總覽公司新聞公告

Opthea Limited盤中異動早盤大幅拉昇5.11%報5.14美元

Opthea Limited盤中異動快速上漲5.65%

Opthea Limited盤中異動股價大漲8.84%

Opthea Limited盤中異動早盤急速上漲5.65%

Opthea Limited盤中異動早盤快速拉昇5.49%報3.95美元

Opthea Limited盤中異動快速跳水5.76%報3.60美元

Opthea Limited盤中異動早盤急速上漲5.45%報3.77美元

Opthea Limited盤中異動早盤股價大漲6.97%

Opthea Limited盤中異動早盤股價大漲8.13%報3.99美元

Opthea Limited盤中異動大幅下挫9.87%報3.54美元

Opthea Limited盤中異動股價大跌9.46%報3.54美元

Opthea Limited盤中異動股價大漲6.22%

Opthea Limited盤中異動早盤急速上漲7.78%

Opthea Limited盤中異動大幅上漲5.73%報3.42美元

Opthea Limited盤中異動早盤快速上漲5.06%

Opthea Limited盤中異動股價大跌5.57%

Opthea Limited盤中異動早盤大幅跳水6.16%

Opthea Limited盤中異動下午盤大幅下挫5.74%

Opthea Limited盤中異動股價大跌5.19%

Opthea Limited盤中異動股價大漲5.11%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CKDXF/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CKDXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CKDXF\",,,,,undefined,":{"symbol":"CKDXF","market":"US","secType":"STK","nameCN":"Opthea Limited","latestPrice":0.44,"timestamp":1744920000000,"preClose":0.44,"halted":0,"volume":0,"delay":15,"floatShares":773174816,"shares":1231094617,"eps":-0.263143,"marketStatus":"耶穌受難日休市","change":0,"latestTime":"04-17 16:00:00 EDT 延時","open":0.44,"high":0.44,"low":0.44,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.263143,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.44,"volumeRatio":0.7068399161573908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CKDXF\",,,,,undefined,":{"symbol":"CKDXF","floatShares":773174816,"roa":"-73.34%","roe":"-3383.08%","lyrEps":-0.345097,"volumeRatio":0.7068399161573908,"shares":1231094617,"dividePrice":0,"high":0.44,"amplitude":0,"preClose":0.44,"low":0.44,"week52Low":0.44,"pbRate":"-3.21","psRate":"2593.53","week52High":0.57,"institutionHeld":0,"latestPrice":0.44,"eps":-0.263143,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.263143,"open":0.44,"prevYearClose":0.44,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.44,"fiveDayClose":0.44,"twentyDayClose":0.44,"sixtyDayClose":0.44},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CKDXF\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506303694","title":"Opthea Limited盤中異動 早盤大幅拉昇5.11%報5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506303694?lang=zh_tw&edition=fundamental","pubTime":"2025-01-27 22:32","pubTimestamp":1737988367,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Opthea Limited股票出现异动，股价急速拉升5.11%。截至发稿，该股报5.14美元/股，成交量2569股，换手率0.00%，振幅0.82%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为722.37%、42.72%、37.87%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为50.00%、18.91%、15.24%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232479874af66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232479874af66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2506867188","title":"Opthea Limited盤中異動 快速上漲5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506867188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506867188?lang=zh_tw&edition=fundamental","pubTime":"2025-01-25 00:00","pubTimestamp":1737734436,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时00分，Opthea Limited股票出现波动，股价快速上涨5.65%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.20%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125000036a22e6e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125000036a22e6e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2505037011","title":"Opthea Limited盤中異動 股價大漲8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505037011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505037011?lang=zh_tw&edition=fundamental","pubTime":"2025-01-23 22:31","pubTimestamp":1737642681,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Opthea Limited股票出现异动，股价大幅拉升8.84%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.02%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223121abb5fa60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223121abb5fa60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2505719672","title":"Opthea Limited盤中異動 早盤急速上漲5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505719672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505719672?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 22:32","pubTimestamp":1737469978,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分，Opthea Limited股票出现异动，股价大幅上涨5.65%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.81%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223258abb346f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223258abb346f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2504162385","title":"Opthea Limited盤中異動 早盤快速拉昇5.49%報3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504162385?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 22:31","pubTimestamp":1737124263,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时31分，Opthea Limited股票出现波动，股价快速拉升5.49%。截至发稿，该股报3.95美元/股，成交量1458股，换手率0.00%，振幅0.27%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.73%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223103a225bb80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223103a225bb80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2503676487","title":"Opthea Limited盤中異動 快速跳水5.76%報3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503676487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503676487?lang=zh_tw&edition=fundamental","pubTime":"2025-01-16 03:02","pubTimestamp":1736967757,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日03时02分，Opthea Limited股票出现异动，股价大幅跳水5.76%。截至发稿，该股报3.60美元/股，成交量9386股，换手率0.01%，振幅5.24%。Opthea Limited股票所在的生物技术行业中，整体涨幅为1.22%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011603023898677583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011603023898677583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2503574302","title":"Opthea Limited盤中異動 早盤急速上漲5.45%報3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503574302?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 22:38","pubTimestamp":1736865480,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时38分，Opthea Limited股票出现异动，股价急速上涨5.45%。截至发稿，该股报3.77美元/股，成交量5822股，换手率0.00%，振幅2.80%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.19%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011422380096038153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2502660862","title":"Opthea Limited盤中異動 早盤股價大漲6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502660862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502660862?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 22:31","pubTimestamp":1736519508,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分，Opthea Limited股票出现异动，股价大幅拉升6.97%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.32%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022314895ff6cda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022314895ff6cda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2501120033","title":"Opthea Limited盤中異動 早盤股價大漲8.13%報3.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501120033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501120033?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 22:31","pubTimestamp":1736260273,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时31分，Opthea Limited股票出现异动，股价急速上涨8.13%。截至发稿，该股报3.99美元/股，成交量219股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.22%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223113985e12d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223113985e12d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2500080927","title":"Opthea Limited盤中異動 大幅下挫9.87%報3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500080927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500080927?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 22:31","pubTimestamp":1735828296,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时31分，Opthea Limited股票出现异动，股价快速下跌9.87%。截至发稿，该股报3.54美元/股，成交量4027股，换手率0.00%，振幅9.17%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.44%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223136a21300bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223136a21300bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2495528205","title":"Opthea Limited盤中異動 股價大跌9.46%報3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495528205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495528205?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 22:31","pubTimestamp":1735569092,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时31分，Opthea Limited股票出现波动，股价快速下挫9.46%。截至发稿，该股报3.54美元/股，成交量1114股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.43%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223132a20f2b02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223132a20f2b02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2494384588","title":"Opthea Limited盤中異動 股價大漲6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494384588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494384588?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 23:26","pubTimestamp":1735313208,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时26分，Opthea Limited股票出现波动，股价大幅上涨6.22%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Galectin Therapeutics Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为101.93%、44.76%、20.21%，振幅较大的相关个股有Galectin Therapeutics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为65.39%、58.33%、51.47%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723264895ef825a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122723264895ef825a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2493976601","title":"Opthea Limited盤中異動 早盤急速上漲7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493976601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493976601?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 22:50","pubTimestamp":1734965435,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时50分，Opthea Limited股票出现异动，股价大幅上涨7.78%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.20%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225035ab8e49da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225035ab8e49da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2493072424","title":"Opthea Limited盤中異動 大幅上漲5.73%報3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493072424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493072424?lang=zh_tw&edition=fundamental","pubTime":"2024-12-21 01:48","pubTimestamp":1734716933,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时48分，Opthea Limited股票出现异动，股价快速上涨5.73%。截至发稿，该股报3.42美元/股，成交量9974股，换手率0.01%，振幅2.79%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.85%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101485395ea9f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101485395ea9f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2492362172","title":"Opthea Limited盤中異動 早盤快速上漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492362172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492362172?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 22:58","pubTimestamp":1734620285,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时58分，Opthea Limited股票出现异动，股价急速上涨5.06%。Opthea Limited股票所在的生物技术行业中，整体跌幅为3.44%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219225805a1fb63e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219225805a1fb63e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2492960527","title":"Opthea Limited盤中異動 股價大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492960527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492960527?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 00:50","pubTimestamp":1734454258,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日00时50分，Opthea Limited股票出现波动，股价快速下跌5.57%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.83%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218005058984c928b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218005058984c928b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2490733386","title":"Opthea Limited盤中異動 早盤大幅跳水6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490733386","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490733386?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 23:38","pubTimestamp":1734017886,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时38分，Opthea Limited股票出现异动，股价急速下跌6.16%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.82%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212233807a1e970ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212233807a1e970ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2490899295","title":"Opthea Limited盤中異動 下午盤大幅下挫5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490899295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490899295?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 02:31","pubTimestamp":1733941919,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日02时31分，Opthea Limited股票出现波动，股价急速下跌5.74%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.14%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212023159a1e6db19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212023159a1e6db19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2489112407","title":"Opthea Limited盤中異動 股價大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489112407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489112407?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 01:25","pubTimestamp":1733333145,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时25分，Opthea Limited股票出现异动，股价快速下跌5.19%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.43%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501254598e5647a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501254598e5647a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2487762550","title":"Opthea Limited盤中異動 股價大漲5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487762550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487762550?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 22:31","pubTimestamp":1732890685,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Opthea Limited股票出现波动，股价急速上涨5.11%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.12%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922312598e46640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112922312598e46640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CKDXF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-30","symbol":"CKDXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1661832000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CKDXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CKDXF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.1667,"hold":0.5,"sell":0.1667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":6,"updateTime":1743566400000}}}